Comparison between [18F]FET PET/MRI and [18F]FET PET/CT in the diagnosis of glioma recurrence: a systematic review and meta-analysis

被引:0
|
作者
Chao Tang
Rongcheng Ruan
Zhaoying Xiong
机构
[1] Graduate Student Training Base of Jinzhou Medical University,Frontier Science Center for Synthetic Biology and Key Laboratory of Systems Bioengineering (Ministry of Education), Department of Neurosurgery
[2] Fushun Mining Bureau General Hospital),Department of Nuclear Medicine
[3] Jinzhou Medical University,undefined
[4] Nanchong Central Hospital,undefined
来源
关键词
PET/CT; PET/MRI; [; F]FET; Glioma recurrence; Meta-analysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:479 / 491
页数:12
相关论文
共 50 条
  • [21] The diagnostic performance of [18F]FDG PET/CT in the detection of melanoma recurrence: a systematic review and meta-analysis
    Zhu, Tingting
    Liao, Maoxin
    Huang, Maoxin
    Xiao, Fengli
    CLINICAL AND TRANSLATIONAL IMAGING, 2024, 12 (05) : 501 - 512
  • [22] Influence of different attenuation correction approaches on dynamic [18F]FET PET/MRI of recurrent glioma
    Rausch, I.
    Haug, A.
    Aghamohammadi-Sareshgi, R.
    Fenchel, M.
    Mayerhoefer, M. E.
    Beyer, T.
    Traub-Weidinger, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S265 - S266
  • [23] Evaluation of the PET component of simultaneous [18F]choline PET/MRI in prostate cancer: comparison with [18F]choline PET/CT
    Wetter, Axel
    Lipponer, Christine
    Nensa, Felix
    Heusch, Philipp
    Ruebben, Herbert
    Altenbernd, Jens-Christian
    Schlosser, Thomas
    Bockisch, Andreas
    Poeppel, Thorsten
    Lauenstein, Thomas
    Nagarajah, James
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (01) : 79 - 88
  • [24] Evaluation of the PET component of simultaneous [18F]choline PET/MRI in prostate cancer: comparison with [18F]choline PET/CT
    Axel Wetter
    Christine Lipponer
    Felix Nensa
    Philipp Heusch
    Herbert Rübben
    Jens-Christian Altenbernd
    Thomas Schlosser
    Andreas Bockisch
    Thorsten Pöppel
    Thomas Lauenstein
    James Nagarajah
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 79 - 88
  • [25] IN VITRO AND IN VIVO EVALUATION OF THE LAT1 PET TRACER 2-[18F]FELP IN COMPARISON TO [18F]FET AND [18F]FDG
    Verhoeven, J.
    Bolcaen, J.
    Kersemans, K.
    De Meulenaere, V.
    Deblaere, K.
    Kalala, J.
    Van den Broecke, C.
    Vanhove, C.
    Goethals, I.
    De Vos, F.
    NEURO-ONCOLOGY, 2017, 19 : 46 - 46
  • [26] [18F]FDG PET/CT outperforms [18F]FDG PET/MRI in differentiated thyroid cancer
    Alexis Vrachimis
    Matthias Christian Burg
    Christian Wenning
    Thomas Allkemper
    Matthias Weckesser
    Michael Schäfers
    Lars Stegger
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 212 - 220
  • [27] [18F]FDG PET/CT outperforms [18F]FDG PET/MRI in differentiated thyroid cancer
    Vrachimis, Alexis
    Burg, Matthias Christian
    Wenning, Christian
    Allkemper, Thomas
    Weckesser, Matthias
    Schaefers, Michael
    Stegger, Lars
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (02) : 212 - 220
  • [28] Head-to-head comparison of [18F]FDG PET/MRI and [18F] FDG PET/CT for TNM staging in non-small cell lung cancer: a systematic review and meta-analysis
    Li, Zhiwei
    Sun, Dianhan
    Li, Anying
    Shu, Yusheng
    CLINICAL AND TRANSLATIONAL IMAGING, 2024, 12 (04) : 413 - 421
  • [29] [18F]FET PET/MRI; a Novel and Improved Technique for Detection of Pituitary Microadenoma
    Pruis, I. J.
    Verburg, F. A.
    Neggers, S. J. C. M.
    Balvers, R. K.
    Smits, M.
    Van Zanten, S. E. M. Veldhuijzen
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S85 - S86
  • [30] Automatic detection and delineation of pediatric gliomas on combined [18F]FET PET and MRI
    Ladefoged, Claes Nohr
    Henriksen, Otto Molby
    Mathiasen, Rene
    Schmiegelow, Kjeld
    Andersen, Flemming Littrup
    Hojgaard, Liselotte
    Borgwardt, Lise
    Law, Ian
    Marner, Lisbeth
    FRONTIERS IN NUCLEAR MEDICINE, 2022, 2